![Jérôme van Biervliet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jérôme van Biervliet
Direttore/Membro del Consiglio presso Exevir Bio BV
Profilo
Jérôme van Biervliet currently works at Waaroost NV, as Director from 2009, Augustine Therapeutics NV, as Director, and Exevir Bio BV, as Director.
Posizioni attive di Jérôme van Biervliet
Società | Posizione | Inizio |
---|---|---|
Exevir Bio BV
![]() Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium. | Direttore/Membro del Consiglio | - |
Waaroost NV | Direttore/Membro del Consiglio | 20/02/2009 |
Augustine Therapeutics NV
![]() Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Waaroost NV | |
Augustine Therapeutics NV
![]() Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Health Services |
Exevir Bio BV
![]() Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Jérôme van Biervliet